Skip to main content

Table 3 Clinical and endocrine characteristics, by PCOS phenotype

From: Polycystic ovary syndrome phenotype does not have impact on oocyte morphology

PCOS B (n = 1) was excluded PCOS A
N = 41
PCOS C
N = 31
PCOS D
N = 37
p value
Woman’s age at first ICSI cycle (y) 29.2 ± 3.2 28.6 ± 4.1 29.1 ± 3.4 0.77
Man’s age (y) 32.9 ± 4,5 32.0 ± 7,2 32.6 ± 4,5 0.80
Current smoking, n (%) 9 (22.0) 14 (45.2) c 5 (13.5) b 0.009
BMI (kg/m2) 27.7 ± 6.7 26.4 ± 6.0 26.3 ± 5.0 0.48
Waist circumference (cm) 86.6 ± 16.3 84.0 ± 14.8 84.6 ± 12.8 0.74
Testosterone (ng/mL) 0.4 ± 0.2c 0.3 ± 0.2 0.3 ± 0.1a 0.004
Delta-4-androstenedione (ng/mL) 2.3 ± 0.7c 2.1 ± 0.7c 1.3 ± 0.4ab < 0.001
LH (IU/L) 5.6 ± 2.6 bc 4.1 ± 1.9a 4.2 ± 2.0a 0.006
FSH (IU/L) 4.8 ± 1.1 5.2 ± 1.4 4.7 ± 1.0 0.23
LH/FSH ratio (IU/L) 1.1 [0.9-1.4] bc 0.8 [0.6-1.0] a 0.8 [0.7-1.2] a < 0.001
AMH (pmol/L) 74.8 ± 37.4 bc 47.3 ± 17.1a 56.2 ± 19.9a < 0.001
FNPO (n) 26.8 ± 10.1 21.7 ± 8.2 23.1 ± 8.0 0.042
  1. Values are quoted as the mean ± standard deviation, the mean [IQR], or n (%)
  2. a p < 0.05 vs. PCOS A after Bonferroni correction
  3. b p < 0.05 vs. PCOS C after Bonferroni correction
  4. c p < 0.05 vs. PCOS D after Bonferroni correction
  5. Abbreviations: y years, BMI body mass index, LH luteinizing hormone, FSH follicle-stimulating hormone, IQR interquartile range, AMH anti-Müllerian hormone, FNPO follicle number per ovary